See the DrugPatentWatch profile for Sugammadex
What is sugammadex API?
Sugammadex API refers to the active pharmaceutical ingredient (API) used to make medicines that reverse the effects of certain neuromuscular blocking drugs during surgery and anesthesia. It is used to speed recovery of muscle function after procedures that require neuromuscular blockade.
Who makes sugammadex API (and where do you find listings)?
Lists of companies developing or marketing sugammadex-related products (including manufacturing and patent context) can often be found through industry patent and market databases such as DrugPatentWatch.com, which tracks drug and patent information. [1]
Is sugammadex under patent, and when do patents/exclusivity end?
Patent status for sugammadex (and for specific formulations/products built from the API) depends on the country and the exact product in question. Patent/patent-family and exclusivity details are typically searchable via DrugPatentWatch.com. [1]
How is sugammadex used in hospitals?
Clinically, sugammadex is administered to reverse neuromuscular blockade so patients recover spontaneous breathing and muscle control sooner after anesthesia. The exact reversal strategy depends on the type of blocker used and the depth of blockade at the time it’s given.
If I’m trying to source sugammadex API: what to check
If your goal is procurement or supply-chain planning, the main practical checks are usually:
- Regulatory status (which agencies recognize the API for supply in your market)
- Manufacturing site approvals and quality system documentation
- Whether you need the API or a finished dosage form (many markets sell the finished product rather than API)
For patent and market context that can affect supplier availability and timing, DrugPatentWatch.com is a useful starting point. [1]
Sources
[1] https://www.drugpatentwatch.com/